BBIO : Insider Transactions for Bridgebio Pharma, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bridgebio Pharma, Inc. (BBIO)

$28.50

0.60 (2.06%) as of 4:30 Mon 5/13

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

173,970,000

Market Cap:

4.96(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$13.29 - $43.89

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	5,415	192,897	1,845,608	2,886,602
Total Sell Value	$195,041	$7,018,061	$62,779,686	$73,415,196
Total People Sold	2	5	6	6
Total Sell Transactions	2	10	16	29
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 288

Page 10 of 12

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Henderson Michael Thomas

See Remarks

• – –

2020-05-05

4

AS

$30.47

$44,493

D/D

(1,460)

162,362

23%

CEO and President

• • –

2020-05-05

4

AS

$30.86

$2,469,482

I/I

(79,600)

2,405,372

23%

Stephenson Brian C

See Remarks

• – –

2020-05-04

4

AS

$30.00

$44,827

D/D

(1,494)

321,622

22%

Henderson Michael Thomas

See Remarks

• – –

2020-05-04

4

AS

$30.01

$39,613

D/D

(1,320)

163,822

22%

CEO and President

• • –

2020-05-04

4

AS

$29.13

$1,177,685

I/I

(39,680)

2,484,972

22%

Stephenson Brian C

See Remarks

• – –

2020-05-01

4

AS

$29.11

$210,474

D/D

(7,200)

323,116

16%

Henderson Michael Thomas

See Remarks

• – –

2020-05-01

4

AS

$29.19

$75,653

D/D

(2,585)

165,142

16%

CEO and President

• • –

2020-05-01

4

AS

$29.06

$1,186,400

I/I

(40,720)

2,524,652

16%

See Remarks

• – –

2020-04-27

4

AS

$32.01

$64,028

D/D

(2,000)

9,823

-9%

See Remarks

• – –

2020-04-27

4

OE

$17.00

$34,000

D/D

2,000

11,823

-

See Remarks

• – –

2020-04-08

4

AS

$27.04

$216,358

D/D

(8,000)

9,823

8%

See Remarks

• – –

2020-04-08

4

OE

$17.00

$136,000

D/D

8,000

17,823

-

CEO and President

• • –

2020-04-07

4

AS

$25.48

$45,983

I/I

(1,805)

2,565,372

22%

Homcy Charles J

Chairman of Pharmaceuticals

• • –

2020-04-03

4

GD

$0.00

$0

D/D

40,000

1,302,291

-

CEO and President

• • –

2020-04-03

4

AS

$25.09

$7,528

I/I

(300)

2,567,177

18%

CEO and President

• • –

2020-04-02

4

AS

$25.04

$395,103

I/I

(15,778)

2,567,477

17%

Stephenson Brian C

See Remarks

• – –

2020-04-01

4

AS

$26.01

$191,610

D/D

(7,200)

330,316

4%

Henderson Michael Thomas

See Remarks

• – –

2020-04-01

4

AS

$25.40

$69,629

D/D

(2,585)

167,727

4%

CEO and President

• • –

2020-04-01

4

AS

$25.52

$1,631,362

I/I

(62,117)

2,583,255

4%

CEO and President

• • –

2020-03-03

4

AS

$31.76

$647,148

I/I

(20,047)

2,645,372

-8%

Henderson Michael Thomas

See Remarks

• – –

2020-03-02

4

AS

$32.20

$128,965

D/D

(3,975)

170,312

-2%

CEO and President

• • –

2020-03-02

4

AS

$31.88

$3,226,883

I/I

(99,953)

2,665,419

-2%

Stephenson Brian C

See Remark

• – –

2020-03-02

4

AS

$31.79

$348,541

D/D

(10,800)

337,516

-2%

Momtazee James C

Director

– • –

2020-02-12

4

A

$0.00

$0

D/D

8,491

8,491

-

See Remarks

• – –

2020-02-11

4

AS

$37.28

$74,564

D/D

(2,000)

9,823

-5%

288 Records found	Previous 10 11 12	Page 10 of 12

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.